Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
TruSignal, LLC offers digital marketing services. It provides display, video, and media campaigns on publisher sites, portals, advertisement networks, trading desks, DSPs, advertisement exchanges, and mobile networks. The company is based in St. Cloud, Minnesota. TruSignal, LLC operates as a subsidiary of xTech Holdings, Inc. As of May 22, 2019, TruSignal, Inc. operates as a subsidiary of TransUnion.
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.
Code42 Software, Inc. is an enterprise SaaS provider specializing in cloud endpoint data protection and security solutions for the business and education sectors. The company's flagship product, Code42 CrashPlan, offers continuous backup of distributed end-user data, enabling organizations to maintain visibility and control over their information. Additionally, Code42 provides Internet2 NET+ CrashPlan, a tailored endpoint backup service for U.S. higher education institutions, and Code42 Next-Gen DLP, a data loss protection solution designed for resource-constrained IT and security teams. The SaaS solution Incydr focuses on safeguarding organizations' intellectual property and sensitive information. With a strategic partnership with Exabeam, Code42 has established itself as a trusted provider, serving over 50,000 organizations globally. Founded in 2001 and headquartered in Minneapolis, Minnesota, the company is backed by prominent investors, including Accel Partners and NEA.
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.
Zyga Technology, Inc. is a medical device company focused on the research, design, development, and commercialization of minimally invasive solutions for lumbar spine conditions. The company offers the SImmetry Sacroiliac Joint Fusion System, which addresses various issues such as sacroiliac joint disruptions and degenerative sacroiliitis. Additionally, Zyga is developing the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology combines a skilled team of engineers, marketing professionals, and management with extensive experience in the spine industry. As of December 31, 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Zyga Technology, Inc. is a medical device company focused on the research, design, development, and commercialization of minimally invasive solutions for lumbar spine conditions. The company offers the SImmetry Sacroiliac Joint Fusion System, which addresses various issues such as sacroiliac joint disruptions and degenerative sacroiliitis. Additionally, Zyga is developing the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology combines a skilled team of engineers, marketing professionals, and management with extensive experience in the spine industry. As of December 31, 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.
Code42 Software, Inc. is an enterprise SaaS provider specializing in cloud endpoint data protection and security solutions for the business and education sectors. The company's flagship product, Code42 CrashPlan, offers continuous backup of distributed end-user data, enabling organizations to maintain visibility and control over their information. Additionally, Code42 provides Internet2 NET+ CrashPlan, a tailored endpoint backup service for U.S. higher education institutions, and Code42 Next-Gen DLP, a data loss protection solution designed for resource-constrained IT and security teams. The SaaS solution Incydr focuses on safeguarding organizations' intellectual property and sensitive information. With a strategic partnership with Exabeam, Code42 has established itself as a trusted provider, serving over 50,000 organizations globally. Founded in 2001 and headquartered in Minneapolis, Minnesota, the company is backed by prominent investors, including Accel Partners and NEA.
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.
Private Equity Round in 2010
Amcom Software specializes in providing communication solutions designed for organizations that require efficient and reliable management of critical communications. Their offerings include advanced software for call center communications, emergency management, wireless messaging middleware, and paging infrastructure. These solutions cater to a diverse range of sectors, including healthcare, hospitality, education, business, industrial, and government. Amcom Software’s products enhance productivity and accuracy in mission-critical situations by offering features such as PC-based attendant consoles, call center recording and quality management, call accounting and reporting, and speech recognition. The company’s software is utilized by numerous leading organizations to streamline their communication processes effectively.
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).
Atritech, based in Minneapolis, Minnesota, is a private company founded in 2000 that specializes in developing innovative technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, is a minimally invasive system designed to close the left atrial appendage, where harmful blood clots can form. This device serves as a permanent alternative to long-term anticoagulation therapy, offering patients a means to reduce their stroke risk associated with non-valvular atrial fibrillation. The WATCHMAN Device has been clinically tested in a large randomized trial comparing its effectiveness to traditional Warfarin therapy. Initially implanted in Germany in 2002 and in the United States in 2003, the device has received CE Mark approval and is available in several international markets, though it is currently designated for investigational use only in the United States.
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.
Kspine was developing implantable medical devices for the treatment of spine disorders.
Calabrio, Inc. is a customer experience intelligence company that specializes in developing and marketing workforce optimization software solutions for call centers. Its flagship product, Calabrio ONE, is an integrated software suite that includes modules for call recording, quality management, workforce management, and analytics, designed to enhance agent performance and customer insights. The company serves a diverse range of industries, including healthcare, telecommunications, retail, and finance, with over 4,000 clients worldwide. In addition to its software offerings, Calabrio provides professional services such as project management, training, and technical support. Founded in 2007 and headquartered in Minneapolis, Minnesota, Calabrio also has locations in Canada, the United Kingdom, Singapore, and Sweden. The company has been recognized as a leader in its field and is affiliated with notable industry programs, positioning it as a key player in optimizing customer experience through innovative technology.
Atritech, based in Minneapolis, Minnesota, is a private company founded in 2000 that specializes in developing innovative technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, is a minimally invasive system designed to close the left atrial appendage, where harmful blood clots can form. This device serves as a permanent alternative to long-term anticoagulation therapy, offering patients a means to reduce their stroke risk associated with non-valvular atrial fibrillation. The WATCHMAN Device has been clinically tested in a large randomized trial comparing its effectiveness to traditional Warfarin therapy. Initially implanted in Germany in 2002 and in the United States in 2003, the device has received CE Mark approval and is available in several international markets, though it is currently designated for investigational use only in the United States.
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.
Gearworks specializes in location-based mobile business applications, partnering with wireless carriers to deliver effective solutions for managing mobile resources. The company offers a range of products under the etrace, Field Force Manager, appmosphere, and OnCare brands. In addition to its mobile management software, Gearworks provides services such as phone programming, provisioning, training, customization, and integration. Its clientele includes small to medium-sized businesses and enterprise customers across various sectors, including construction, healthcare, field service, home and store delivery, utilities, and government services.
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.
Atritech, based in Minneapolis, Minnesota, is a private company founded in 2000 that specializes in developing innovative technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, is a minimally invasive system designed to close the left atrial appendage, where harmful blood clots can form. This device serves as a permanent alternative to long-term anticoagulation therapy, offering patients a means to reduce their stroke risk associated with non-valvular atrial fibrillation. The WATCHMAN Device has been clinically tested in a large randomized trial comparing its effectiveness to traditional Warfarin therapy. Initially implanted in Germany in 2002 and in the United States in 2003, the device has received CE Mark approval and is available in several international markets, though it is currently designated for investigational use only in the United States.
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.
Spanlink Communications, Inc. provides business communications technology and network integration solutions in the United States and internationally. It offers packaged applications, such as Spanlink Courtesy Callback that improves customer satisfaction and agent utilization rates; Customer Survey Manager, which provides users with a solution for creating, launching, and managing automated customer feedback surveys; Spanlink Top Customer that enables users to give designated customers attention; and SolutionWatch, an enterprise-grade application monitoring and systems reporting tool to provide alerts on flaws in the voice and data network. The company also provides CentralControl, a system management product that provides the multi-tenancy to manage voice network, enables senior level control at the data center, and provides access for routine changes at the edge; and IVR toolkits for unified customer voice portal, unified contact center enterprise, and unified contact center express platforms. In addition, it offers analysis, design, implementation, validation, launch, transition, and support services; consultative and assessment services, such as solution value analysis, voice readiness assessment, recording studio, reporting assessment, simulation testing, and post-deployment assessment services; and planning, migration, and support services. Further, Spanlink Communications provides contact center solutions, such as unified communications, unified customer contact, and network systems solutions; and interactive intelligence solutions, including enterprise IP telephony, contact center, hosted and on-premise contact center, and business process automation solutions. The company integrates unified communications, customer interaction, workforce optimization, and system management products that exploit the benefits of VoIP network infrastructures. Spanlink Communications, Inc. was founded in 1988 and is based in Minneapolis, Minnesota.